InvestorsHub Logo
Followers 139
Posts 10688
Boards Moderated 0
Alias Born 01/25/2010

Re: None

Thursday, 01/26/2017 11:56:17 AM

Thursday, January 26, 2017 11:56:17 AM

Post# of 409
ADVT is setting up for a big move MJ hidden GEM.. is a matter of time till it will break out big time.. is already trading above some major technical support and with all the upcoming great news.. this 3/4 mil vols a day will not last long..
check this out.. I have pull the chart to see PPs history last few yrs..as the SS hasn't changed since 2000.. so I went back and look into the former co .. it seems they always have been into MJ field... just not much of attention ever.. lol


that spiked in 2014 happened on very low'ish volume.. and now it looks like first accumulation ever as no SS changed since 2000
Security Notes

•New Issue=10-87 12,000,000 shs in units (1 sh Com, 1 Class A Warr 12-17-88 & 1 Class B Warr 12-17-89) at 3 cents per unit (best efforts-4,000,000 min.) by Sprung & Wise Securities, Inc
•Capital Change=shs increased by 5 for 1 split. Ex-date=04/14/2000. Rec date=03/24/2000. Pay date=04/13/2000.
•Capital Change=shs increased by 5 for 1 split. Ex-date=04/14/2000. Rec date=03/24/2000. Pay date=04/13/2000.




http://stockcharts.com/h-sc/ui?s=ADVT&p=D&yr=5&mn=0&dy=0&id=p05348098199


http://www.otcmarkets.com/stock/ADVT/news/RAMOIL-MANAGEMENT--Ltd-Begins-Sales-Of-Its-Proprietary--quot-RAMO-CBD-Pain-quot--And-THC-Formulated-Product-Lines?id=91899&b=y



wait till everyone will learn bout it..IMO is just a not well known player in the field..


Quote:
Dec 1, 2015 Ramoil Management Announces Name Change to Advantis Corp and a New Distribution agreement


Advantis Corp. Appoints Chief Medical Director to Develop CBD Based Nutraceuticals

Quote:
Advantis CEO, Christopher Swartz says that Dr. Elgin will additionally be responsible for testing the efficacy of products Advantis acquires and distributes. Swartz shares the doctor's excitement about the future of CBD technology. "I am passionate about finding effective solutions to cure this chronic pain epidemic," Swartz stated. "Dr. Elgin has been working with me at Sequence Therapy to develop proper exercises, and now at Advantis we will work together to develop effective medicines." Advantis has been working with medical marijuana provider, Natural Elements, who will be providing the CBD materials for research and development of nutraceutical products that can be used used orally (including its infusion into food and beverage products), topically, or through inhalation. "I am excited that Dr. Elgin shares my passion for providing for millions of people suffering from chronic pain," Swartz said. "Together, with Natural Elements, and Sequence Therapy, Advantis will make giant steps toward bringing a revolutionary pain relief process to those in need."

Swartz also mentioned that the search for viable properties by Advantis subsidiaries to produce and provide marijuana and its extracts in Oregon and Washington has entered a new stage. "We are aggressively working to identify real estate that can be properly permitted and/or partners that have a permitted operation in place," Swartz said. "We are stepping up our efforts with EARSI and two of the top medical marijuana attorneys in Oregon and Washington." A previous property that was identified did not meet certain standards required to properly permit it for a viable operation. "We are stepping on the gas pedal to get things moving as fast as possible, while adhering to the states strict guidelines," Swartz concluded.

Swartz also commented that he will soon reveal the details of a semi-exclusive packaging agreement that has recently been reached to license and provide innovative packaging solutions to dispensaries.

http://www.otcmarkets.com/stock/ADVT/news/Advantis-Corp--Appoints-Chief-Medical-Director-to-Develop-CBD-Based-Nutraceuticals?id=130845&b=y

ADVT a new MJ Co... running completely under the radars.. recent news

surging revenues: "Initial demand has surpassed even our most aggressive projections," Swartz reflected, "and we are securing new clients every week. If we continue this trajectory, we will be household name in the industry very soon."


OTC Disclosure & News Service

http://www.otcmarkets.com/stock/ADVT/news
Authorized Shares 1,000,000,000 a/o Jan 01, 2016
Outstanding Shares 918,969,715 a/o Aug 23, 2016








Release Date


Title


Type


Jan 23, 2017 Advantis Corp. Developing Rosin Press for Home Use Press Release
Jan 17, 2017 Advantis Corp. Boosts Bottom Line, Reduces Debt Press Release
Jan 10, 2017 Advantis Corp. Rolls Out New Products Press Release
Jan 3, 2017 Advantis Corp. Acquires Large Commercial Space Press Release
Dec 19, 2016 Advantis Corp. Reviews Progress, Forecasts Revenue Explosion for 2017 Press Release
Dec 5, 2016 Advantis Corp. Acquires Rights to Nugsmasher Line of Rosin Presses Press Release
Nov 30, 2016 Advantis Corp. Amstercan Sales Increase Three-Fold Press Release
Nov 21, 2016 Advantis Corp. Surging Sales Lead to Premium Product Development Press Release
Nov 17, 2016 Advantis Corp. Launches Rosin6 Marketing Campaign, Announces First Sales Press Release
Nov 14, 2016 Advantis Corp. Forges New Trail In Cannabis Extraction, Developing New Product Lines Press Release
Nov 10, 2016 Advantis Corp. Lauds Passage of California's Prop 64 Press Release
Nov 7, 2016 Advantis Corp. Signs Distribution Agreement with California's Largest Medical Marijuana Delivery Service Press Release
Nov 4, 2016 Advantis Corp. Launches New Revolutionary Rosin6 Rosin Press Press Release
Nov 1, 2016 Prop 64 Voting Fuels Cannabis Sector -- Advantis Corp. to Expand on Distribution Deals Across the Country and in Final Stages on Agreement with one of California's Largest Delivery Services Press Release
Sep 20, 2016 Advantis Corp. Licenses Amstercan Packaging Process, Brands OG Kush, Blue Dream, and Gorilla Glue Press Release
Sep 14, 2016 Advantis Corp. Receives Revolutionary Patented Packaging Equipment for Preserving Cannabis Press Release
Aug 30, 2016 Advantis CEO, Christopher Swartz, Addresses Recent Unauthorized Promotion of Advantis Stock by Stellar Media Group and Others. Press Release
Aug 29, 2016 Advantis CEO, Christopher Swartz, Addresses Recent Unauthorized Promotion of Advantis Stock by Stellar Media Group and Others. Press Release
Jun 27, 2016 Advantis Corp. Announces Critical Talks With Leafhead.com and Hires Chief Compliance Officer of Operations Press Release
Jun 22, 2016 Advantis Corp. Signs Licensing Agreement With N2 Packaging Systems Press Release
Jun 13, 2016 Advantis CEO, Christopher Swartz, is Featured in an Exclusive New Interview at SmallCapVoice.com Press Release
Jun 7, 2016 Advantis Corp. Announces Relationship With Major Hemp/CBD Manufacturer Out of Colorado Press Release
May 3, 2016 Advantis Corp. Appoints Chief Medical Director to Develop CBD Based Nutraceuticals Press Release
Mar 28, 2016 New Advantis Corp. CEO Shares Vision, Identifies Future Revenue Press Release
Mar 21, 2016 Advantis Corp. Delivers Products and Services to California Medical Marijuana Business Press Release
Mar 15, 2016 Advantis Adds Firepower to Executive Team Press Release
Feb 22, 2016 Advantis Corp. Delivers LipMedRX to Southern California Retailer Press Release
Feb 10, 2016 Advantis Corp. Establishes Advantis Cannabis, LLC in Washington Press Release
Feb 1, 2016 Advantis Corp. Signs Contract With Regulatory and Environmental Consultant, EARSI Press Release
Jan 27, 2016 Advantis Corp. Steps Toward Oregon Cannabis Market Press Release
Jan 19, 2016 Advantis Corp. Searches for West Coast Distribution Hub Press Release
Jan 11, 2016 Advantis Corp. Recaps 2015, Moves Corporate Office Press Release
Dec 28, 2015 Advantis Corp Signs Contract With 7-Eleven and 76 Station Franchises Press Release
Dec 7, 2015 Advantis Corp. Announces Negotiations With Major Retail Chain Press Release
Dec 1, 2015 Ramoil Management Announces Name Change to Advantis Corp and a New Distribution agreement Press Release
Nov 9, 2015 Ramoil Management, Ltd. CEO Interview Details Future, Reveals New Company Name Press Release









Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.